Secukinumab on Refractory Lupus Nephritis

Lupus nephritis (LN) is the most frequent severe organ manifestation of systemic lupus erythematosus (SLE). About 30% of patients are refractory to treatment. The authors report a case of treatment of LN with interleukin-17-targeted therapy, demonstrating its possible benefit, after reports of T hel...

Descripción completa

Detalles Bibliográficos
Autores principales: Costa, Rita, Antunes, Paula, Salvador, Pedro, Oliveira, Pedro, Marinho, António
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439396/
https://www.ncbi.nlm.nih.gov/pubmed/34540426
http://dx.doi.org/10.7759/cureus.17198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439396/
https://www.ncbi.nlm.nih.gov/pubmed/34540426
http://dx.doi.org/10.7759/cureus.17198

Ejemplares similares